Rockefeller Capital Management L.P. Has $224.81 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Rockefeller Capital Management L.P. increased its position in shares of Colgate-Palmolive (NYSE:CL) by 0.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,165,600 shares of the company’s stock after acquiring an additional 14,032 shares during the quarter. Colgate-Palmolive comprises about 0.6% of Rockefeller Capital Management L.P.’s investment portfolio, making the stock its 22nd largest position. Rockefeller Capital Management L.P. owned approximately 0.27% of Colgate-Palmolive worth $224,806,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in CL. E Fund Management Hong Kong Co. Ltd. acquired a new position in Colgate-Palmolive during the 2nd quarter valued at about $25,000. Continuum Advisory LLC boosted its stake in Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after acquiring an additional 125 shares during the last quarter. Reston Wealth Management LLC acquired a new stake in Colgate-Palmolive during the 3rd quarter worth $42,000. Capital Performance Advisors LLP bought a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at $53,000. Finally, Prospera Private Wealth LLC acquired a new position in shares of Colgate-Palmolive in the 3rd quarter valued at $64,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 0.2 %

Colgate-Palmolive stock opened at $96.76 on Friday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The firm has a 50-day moving average of $97.51 and a 200-day moving average of $98.57. The company has a market cap of $79.05 billion, a price-to-earnings ratio of 27.73, a P/E/G ratio of 3.45 and a beta of 0.42. Colgate-Palmolive has a one year low of $75.50 and a one year high of $109.30.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.07%. The ex-dividend date was Friday, October 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.31%.

Analyst Ratings Changes

A number of equities research analysts recently commented on CL shares. Deutsche Bank Aktiengesellschaft cut Colgate-Palmolive from a “buy” rating to a “hold” rating and lifted their price objective for the stock from $107.00 to $109.00 in a research note on Monday, September 9th. JPMorgan Chase & Co. increased their price target on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Stifel Nicolaus lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $105.00 to $101.00 in a research note on Monday, October 28th. UBS Group increased their target price on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Finally, Redburn Atlantic raised shares of Colgate-Palmolive to a “hold” rating in a report on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive has a consensus rating of “Moderate Buy” and a consensus target price of $105.11.

Insider Transactions at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.